Bo Wei
Impact in
-
- Traditional Chinese Medicine Analysis
- Pathology and Forensic Medicine top 10%
- Cardiac Ischemia and Reperfusion
Papers in
-
- Cardiac Ischemia and Reperfusion 14
-
- Drug-Induced Hepatotoxicity and Protection 4
- Co-authors
- Hui Ji (4 shared papers)Qinghua Hu (2 shared papers)Wenwen Li (2 shared papers)Xia Xu (9 shared papers)Jingjing Ling (3 shared papers)Xinying Wang (4 shared papers)Ji Zhang (5 shared papers)Jing Ji (1 shared paper)
- Journals
- European Journal of Medicinal Chemistry (3 papers)Phytomedicine (3 papers)Biomedical Chromatography (2 papers)European Journal of Pharmacology (2 papers)Phytotherapy Research (2 papers)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Bo Wei
33 papers receiving 883 citations
Peers
Comparison fields: 5 of 76
- Complementary and alternative medicine 144
- Pathology and Forensic Medicine 165
- Geriatrics and Gerontology 21
- Pharmacology 49
- Drug Discovery 1
Countries citing papers authored by Bo Wei
This map shows the geographic impact of Bo Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Wei more than expected).
Fields of papers citing papers by Bo Wei
This network shows the impact of papers produced by Bo Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Wei. The network helps show where Bo Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 85 | |
| 2 | 2021 | 80 | |
| 3 | 2013 | 79 | |
| 4 | 2015 | 72 | |
| 5 | 2020 | 67 | |
| 6 | 2018 | 66 | |
| 7 | 2011 | 44 | |
| 8 | 2019 | 43 | |
| 9 | 2020 | 43 | |
| 10 | 2021 | 40 | |
| 11 | 2021 | 36 | |
| 12 | 2022 | 32 | |
| 13 | 2018 | 31 | |
| 14 | 2023 | 20 | |
| 15 | 2019 | 18 | |
| 16 | 2021 | 16 | |
| 17 | 2023 | 15 | |
| 18 | 2021 | 14 | |
| 19 | 2024 | 13 | |
| 20 | 2022 | 11 |
About Bo Wei
Bo Wei is a scholar working on Pathology and Forensic Medicine, Pharmacology, Complementary and alternative medicine, Health, Toxicology and Mutagenesis and Molecular Biology, having authored 36 papers that have together received 892 indexed citations. Recurring topics across this work include Cardiac Ischemia and Reperfusion (14 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Effects and risks of endocrine disrupting chemicals (3 papers), Traditional Chinese Medicine Analysis (3 papers), Genomics, phytochemicals, and oxidative stress (3 papers), Ferroptosis and cancer prognosis (3 papers), Histone Deacetylase Inhibitors Research (2 papers) and Autophagy in Disease and Therapy (2 papers). The work is most often cited by research in Complementary and alternative medicine (144 citations), Pathology and Forensic Medicine (165 citations), Geriatrics and Gerontology (21 citations), Pharmacology (49 citations) and Drug Discovery (1 citation). Bo Wei has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Hui Ji, Qinghua Hu, Wenwen Li, Xia Xu, Jingjing Ling, Xinying Wang, Ji Zhang, Jing Ji, Yaxin Sun and Qiao Lin. Their work appears in journals such as European Journal of Medicinal Chemistry, Phytomedicine, Biomedical Chromatography, European Journal of Pharmacology and Phytotherapy Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.